Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II

Human Gene Therapy
Taichi WakabayashiToya Ohashi

Abstract

Mucopolysaccharidosis type II (MPS II) is a neuropathic lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase (IDS), which leads to the accumulation of glycosaminoglycans (GAGs). We demonstrated that biochemical alterations in the brains of MPS II mice are not corrected by bone marrow transplantation (BMT) or enzyme replacement therapy, although BMT has been shown to be effective for other neurodegenerative MPSs, such as Hurler syndrome. In this study, we demonstrated that lentiviral isogeneic hematopoietic stem cell (HSC) gene therapy corrected neuronal manifestations by ameliorating lysosomal storage and autophagic dysfunction in the brains of MPS II mice. IDS-transduced HSCs increased enzyme activity both in various visceral organs and the CNS. Decreased levels of GAGs were observed in many organs, including cerebra, after transplantation of IDS-transduced HSCs. In addition, lentiviral HSC gene therapy normalized the secondary accumulation of autophagic substrates, such as p62 and ubiquitin-protein conjugates, in cerebra. Furthermore, in contrast to naive MPS II mice, there was no deterioration of neuronal function observed in transplant recipients. These results indicated that lentiviral HSC gene therap...Continue Reading

References

Jan 1, 1983·Developmental Neuroscience·E Conzelmann, K Sandhoff
Jan 1, 1995·Journal of Inherited Metabolic Disease·E G ShapiroW Krivit
Jul 10, 1999·Journal of Inherited Metabolic Disease·A VellodiJ E Wraith
Dec 20, 2003·Pediatric Neurology·J Jeffrey MalatackEliel Bayever
May 7, 2004·The New England Journal of Medicine·Susan L StabaJoanne Kurtzberg
Apr 27, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Hiroshi KobayashiDonald B Kohn
Jun 23, 2005·Acta Neuropathologica·Takahiro FukudaShinichiro Umemura
Aug 17, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Joseph MuenzerAlan Kimura
Nov 3, 2006·The Journal of Clinical Investigation·Alessandra BiffiLuigi Naldini
Nov 10, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Josef PrillerAdriano Aguzzi
May 17, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Takahiro KimuraRenata Stripecke
Sep 19, 2007·Journal of Inherited Metabolic Disease·A R GarciaJ Muenzer
Oct 5, 2007·Human Molecular Genetics·Carmine SettembreAndrea Ballabio
Jan 2, 2009·Pediatrics·Joseph MuenzerUNKNOWN International Consensus Panel on Management and Treatment of Mucopolysaccharidosis I
Jan 27, 2009·The Journal of Pediatrics·Nathalie GuffonRoseline Froissart
Aug 15, 2009·American Journal of Human Genetics·Vinicia Assunta Polito, Maria Pia Cosma
Sep 17, 2010·Nature·Marina Cavazzana-CalvoPhilippe Leboulch
Sep 30, 2010·Human Molecular Genetics·Vinicia Assunta PolitoMaria Pia Cosma
Dec 15, 2010·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Joseph MuenzerAlan Kimura
Apr 6, 2011·Journal of Inherited Metabolic Disease·Renzo ManaraMaurizio Scarpa
Dec 23, 2011·Stem Cells International·Ekati DrakopoulouNicholas P Anagnou
Jan 11, 2012·Nature Chemical Biology·Roger LawrenceBrett E Crawford
May 2, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alexander Langford-SmithBrian W Bigger
Jun 1, 2012·Autophagy·Andrew P LiebermanAndrea Ballabio
Aug 9, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rustom FalahatiKarin Ml Gaensler
Aug 9, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Toya OhashiHiroshi Kobayashi
Jun 12, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ana SergijenkoBrian W Bigger

❮ Previous
Next ❯

Citations

Nov 26, 2015·Human Molecular Genetics·Alessandra Biffi
Apr 9, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alessandra Biffi
Oct 17, 2017·Human Gene Therapy·Françoise PiguetNathalie Cartier
Nov 20, 2018·Journal of Human Genetics·Hiroshi Kobayashi
Jun 10, 2018·EMBO Molecular Medicine·Hélène Fe GleitzBrian W Bigger
Feb 20, 2020·International Journal of Molecular Sciences·Francesca D'AvanzoRosella Tomanin
Jul 18, 2019·Clinical & Translational Immunology·Steven M Heaton
Jun 24, 2020·Blood Advances·Brigitte T A van den BroekPeter M van Hasselt
Nov 19, 2015·Journal of Inherited Metabolic Disease·Shunji TomatsuMarta Serafini
May 28, 2019·Genetics and Molecular Biology·Edina PolettoGuilherme Baldo
Nov 22, 2017·Expert Opinion on Orphan Drugs·Molly StapletonShunji Tomatsu
Nov 18, 2018·Italian Journal of Pediatrics·Alessandro FraldiMaria Ester Bernardo
Aug 11, 2020·Molecular Therapy. Methods & Clinical Development·Giuseppa PirasH Bobby Gaspar
Apr 25, 2021·Seminars in Pediatric Neurology·Kim L McBride, Kevin M Flanigan
Jun 3, 2021·International Journal of Molecular Sciences·Paweł Zapolnik, Antoni Pyrkosz
Nov 4, 2020·Current Pharmaceutical Design·Francyne KubaskiRoberto Giugliani
Aug 8, 2021·International Journal of Molecular Sciences·Christiane S HampeR Scott McIvor

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
enzyme-linked immunosorbent assay
protein assay

Software Mentioned

JMP
MACSQuantify

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.